Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells. | Pharmaceutics | 2022 | 36297474 | PubTator, text mining | PubMed |
| A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). | Pharmaceutics | 2022 | 36297446 | PubTator, text mining | PubMed |
| PET Oncological Radiopharmaceuticals: Current Status and Perspectives. | Molecules | 2022 | 36296381 | PubTator, text mining | PubMed |
| The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 36294448 | PubTator, text mining | PubMed |
| Congenital Hyperinsulinaemic Hypoglycaemia-A Review and Case Presentation. | J Clin Med | 2022 | 36294341 | PubTator, text mining | PubMed |
| Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy. | Int J Mol Sci | 2022 | 36293222 | PubTator, text mining | PubMed |
| Endocrine and Neuroendocrine Tumors: A Special Issue. | Cancers (Basel) | 2022 | 36291777 | PubTator, text mining | PubMed |
| Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation. | J Imaging | 2022 | 36286355 | PubTator, text mining | PubMed |
| Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study. | Front Surg | 2022 | 36277293 | PubTator, text mining | PubMed |
| Laparoscopic treatment for an intrapancreatic accessory spleen: A case report. | Front Oncol | 2022 | 36276164 | PubTator, text mining | PubMed |
| Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose. | Front Med (Lausanne) | 2022 | 36275809 | PubTator, text mining | PubMed |
| Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. | Nat Commun | 2022 | 36271074 | PubTator, text mining | PubMed |
| Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR. | Endocr Connect | 2022 | 36269605 | PubTator, text mining | PubMed |
| Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. | Cell Oncol (Dordr) | 2022 | 36269546 | PubTator, text mining | PubMed |
| Histone deacetylases modulate resistance to the therapy in lung cancer. | Front Genet | 2022 | 36263432 | PubTator, text mining | PubMed |
| Putting on molecular weight: Enabling cryo-EM structure determination of sub-100-kDa proteins. | Curr Res Struct Biol | 2022 | 36248264 | PubTator, text mining | PubMed |
| Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents. | Molecules | 2022 | 36235168 | PubTator, text mining | PubMed |
| Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells. | Molecules | 2022 | 36235124 | PubTator, text mining | PubMed |
| Bioinformatics and Experimental Analyses Reveal Immune-Related LncRNA-mRNA Pair AC011483.1-CCR7 as a Biomarker and Therapeutic Target for Ischemic Cardiomyopathy. | Int J Mol Sci | 2022 | 36233294 | PubTator, text mining | PubMed |
| Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors. | Cancers (Basel) | 2022 | 36230691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=43